Journal of Pain Vol. 9

  • the journal of painJune 2008, Journal of Pain Vol. 9, Issue 6, Pages 505-521

    Barth Wilsey, MD, Director of the University of California at Davis Analgesic Research Center, et al., stated the following in their June 2008 study titled “A Randomized, Placebo Controlled Cross-Over Trial of Cannabis Cigarettes in Neuropathic Pain,” published in the Journal of Pain:

    “This study’s objective was to examine the efficacy of two doses of smoked cannabis on pain in persons with neuropathic pain of different origins (e.g., physical trauma to nerve bundles, spinal cord injury, multiple sclerosis, diabetes). In a double-blind, randomized clinical trial participants received either lowdose, high-dose, or placebo cannabis cigarettes…

    Thirty-eight patients underwent a standardized procedure for smoking either high-dose (7%), low-dose (3.5%), or placebo cannabis; of these, 32 completed all three smoking sessions. The study demonstrated an analgesic response to smoking cannabis with no significant difference between the low and the high dose cigarettes. The study concluded that both low and high cannabis doses were efficacious in reducing neuropathic pain of diverse causes.”

  • Tags: , ,
  • Comments